Why Did CARISMA Therapeutics Plunge 13.1%?

On June 12, 2025, CARISMA Therapeutics experienced a significant drop of 13.1% in pre-market trading, reflecting a notable shift in investor sentiment.

In recent weeks, CARISMA Therapeutics has seen dramatic fluctuations in its stock price. On June 10, the company's stock surged by 74.89% in pre-market trading, indicating a period of intense market interest. However, this rally was followed by a substantial correction, with the stock experiencing a -45.66% loss during regular trading hours on the same day. This volatility highlights the speculative nature of the market's response to the company's recent developments.

Additionally, the company faced challenges such as declining sales and a trending fatal crash report, which contributed to a 17% drop in its stock price over a 48-hour period. These factors, combined with broader market dynamics, have led to a period of uncertainty for CARISMA Therapeutics, as investors grapple with the company's future prospects.